SecBot SecBot
8-K ·Filed Jul 28, 2026

VXRT

Vaxart, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001437749-26-024560
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

This is a routine governance filing with no trading implications. Monitor next quarterly report for pipeline updates and cash runway, which are the primary value drivers for VXRT.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$0.4800
T+0 close · Jul 28, 2026 · via day close
Latest settled
+2.08%
T+60 · $0.4900
Vs SPY
−2.53%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 28 $0.4800entry
  2. T+1 · 4mo ago 0.00%α +1.54% · $0.4800
  3. T+5 · 4mo ago +25.00%α +20.89% · $0.6000
  4. T+20 · 3mo ago +4.17%α +0.79% · $0.5000
  5. T+60 · 27d ago +2.08%α −2.53% · $0.4900

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vaxart filed an 8-K reporting a routine reorganization of its Board committees, appointing Kevin P. Finney as chair of the Nominating and Governance Committee and James B. Breitmeyer as chair of the Compensation Committee, effective August 1, 2026. This is an administrative governance change with no financial or operational impact on the company's business, pipeline, or financial position. The filing contains no financial data, guidance, or material events.

Key Facts

  • Board reorganized Nominating and Governance Committee and Compensation Committee on July 27, 2026.
  • Kevin P. Finney appointed chair of Nominating and Governance Committee.
  • James B. Breitmeyer, M.D., Ph.D. appointed chair of Compensation Committee.
  • Changes effective August 1, 2026.
  • No financial data, guidance, or material business events disclosed.

Financial Impact

None, no financial impact disclosed.

Risk Factors

  • No material risks disclosed in this filing.

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-024560
Document: 0001437749-26-024560-index-headers.html0001437749-26-024560
Document: 0001437749-26-024560-index.html0001437749-26-024560
Document: 0001437749-26-024560.txt0001437749-26-024560

Track record

23 reports on VXRT

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +37.66% at T+60 after the May 1, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $0.3700 Now $0.3600 +2.70% settles Feb 4
  2. Oct 19, 202628d ago 8-K Neutral 3/10 Entry $0.4900 Now $0.3600 −26.53% settles Jan 15
  3. Jul 28, 202615w ago 8-K Neutral 2/10 Viewing Entry $0.4800 to $0.4900 Now $0.3600 −25.00% ▲ +2.08% −2.53% vs SPY
  4. Jul 7, 202618w ago 8-K Neutral 4/10 Entry $0.5500 to $0.4500 Now $0.3600 −34.55% ▼ −18.18% −21.27% vs SPY
  5. Jul 6, 202619w ago DEFA14A Neutral 5/10 Entry $0.6200 to $0.4540 Now $0.3600 −41.94% ▼ −26.77% −28.93% vs SPY
  6. Jul 2, 202619w ago DEFA14A Bullish 5/10 Entry $0.6400 to $0.4500 Now $0.3600 −43.75% ▼ −29.69% −33.51% vs SPY
  7. Jul 2, 202619w ago 8-K Neutral 4/10 Entry $0.6400 to $0.4520 Now $0.3600 −43.75% ▼ −29.38% −32.80% vs SPY
  8. Jun 26, 202620w ago DEFA14A Neutral 4/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
  9. Jun 26, 202620w ago DEFA14A Neutral 3/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
  10. Jun 26, 202620w ago 8-K Mixed 5/10 Entry $0.5700 to $0.4900 Now $0.3600 −36.84% ▼ −14.04% −17.08% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 28, 2026